University of Michigan

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2023) Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, et al. Journal article Bounds on heat transfer by incompressible flows between balanced sources and sinks (2023) Song B, Fantuzzi G, Tobasco I Journal article, Original article Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes (2023) Agarwal R, Ruilope LM, Ruiz-Hurtado G, Haller H, Schmieder R, Anker SD, Filippatos G, et al. Journal article Supporting the Transition to Climate-Neutral Production: An Evaluation Under the Agreement on Subsidies and Countervailing Measures (2023) Ismer R, van Asselt H, Haverkamp J, Mehling M, Neuhoff K, Pirlot A Journal article Overview of the Advanced X-ray Imaging Satellite (AXIS) (2023) Reynolds CS, Kara EA, Mushotzky RF, Ptak A, Koss MJ, Williams BJ, Allen SW, et al. Conference contribution Guidelines for neuroprognostication in adults with traumatic spinal cord injury (2023) Mahanes D, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Busl KM, Creutzfeldt CJ, et al. Journal article Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage (2023) Hwang DY, Kim KS, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Busl KM, et al. Journal article Author Correction: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome (Neurocritical Care, (2023), 38, 3, (564-583), 10.1007/s12028-023-01707-3) (2023) Busl KM, Fried H, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Creutzfeldt CJ, et al. Journal article, Erratum Correction to: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome (Neurocritical Care, (2023), 10.1007/s12028-023-01707-3) (2023) Busl KM, Fried H, Muehlschlegel S, Wartenberg KE, Rajajee V, Alexander SA, Creutzfeldt CJ, et al. Journal article, Erratum Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial (2023) McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JF, Marx N, Mulvagh SL, et al. Journal article